Evidence map›Paper›PMID 38940175›Full record

ArticleBioinformatics (Oxford, England)2024

Scalable de novo classification of antibiotic resistance of Mycobacterium tuberculosis.

Mohammadali Serajian, Simone Marini, Jarno N Alanko, Noelle R Noyes, Mattia Prosperi, Christina Boucher

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Tokenization and deep learning architectures in genomics: A comprehensive review.Computational and structural biotechnology journal · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mohammadali SerajianDepartment of Computer and Information Science and Engineering, University of Florida, 1889 Museum Road, Gainesville, Florida 32611, United States.ORCID 0009-0004-8274-0121
Simone MariniDepartment of Epidemiology, University of Florida, PO Box 100231, Gainesville, Florida 32601, United States.ORCID 0000-0002-5704-3533
Jarno N AlankoDepartment of Computer Science, University of Helsinki, P.O. Box 4, Helsinki 00014, Finland.ORCID 0000-0002-8003-9225
Noelle R NoyesDepartment of Veterinary Population Medicine, University of Minnesota, 1365 Gortner Avenue, St. Paul, Minnesota 55108, United States.ORCID 0000-0001-6149-1008
Mattia ProsperiDepartment of Epidemiology, University of Florida, PO Box 100231, Gainesville, Florida 32601, United States.ORCID 0000-0002-9021-5595
Christina BoucherDepartment of Computer and Information Science and Engineering, University of Florida, 1889 Museum Road, Gainesville, Florida 32611, United States.ORCID 0000-0001-9509-9725

Funding

Developing Computational Methods for Surveillance of Antimicrobial Resistant AgentsR01AI141810 · NIAID · UNIVERSITY OF FLORIDA · PI BOUCHER, CHRISTINA, PROSPERI, MATTIA · 2019 to 2023
$2.1M
NIAID NIH HHS R01 AI141810NIAID NIH HHS R01AI141810NIHNSF 2118251
6 · The paper itself

Abstract

motivationWorld Health Organization estimates that there were over 10 million cases of tuberculosis (TB) worldwide in 2019, resulting in over 1.4 million deaths, with a worrisome increasing trend yearly. The disease is caused by Mycobacterium tuberculosis (MTB) through airborne transmission. Treatment of TB is estimated to be 85% successful, however, this drops to 57% if MTB exhibits multiple antimicrobial resistance (AMR), for which fewer treatment options are available.

resultsWe develop a robust machine-learning classifier using both linear and nonlinear models (i.e. LASSO logistic regression (LR) and random forests (RF)) to predict the phenotypic resistance of Mycobacterium tuberculosis (MTB) for a broad range of antibiotic drugs. We use data from the CRyPTIC consortium to train our classifier, which consists of whole genome sequencing and antibiotic susceptibility testing (AST) phenotypic data for 13 different antibiotics. To train our model, we assemble the sequence data into genomic contigs, identify all unique 31-mers in the set of contigs, and build a feature matrix M, where M[i, j] is equal to the number of times the ith 31-mer occurs in the jth genome. Due to the size of this feature matrix (over 350 million unique 31-mers), we build and use a sparse matrix representation. Our method, which we refer to as MTB++, leverages compact data structures and iterative methods to allow for the screening of all the 31-mers in the development of both LASSO LR and RF. MTB++ is able to achieve high discrimination (F-1 >80%) for the first-line antibiotics. Moreover, MTB++ had the highest F-1 score in all but three classes and was the most comprehensive since it had an F-1 score >75% in all but four (rare) antibiotic drugs. We use our feature selection to contextualize the 31-mers that are used for the prediction of phenotypic resistance, leading to some insights about sequence similarity to genes in MEGARes. Lastly, we give an estimate of the amount of data that is needed in order to provide accurate predictions. AVAILABILITY: The models and source code are publicly available on Github at https://github.com/M-Serajian/MTB-Pipeline.

Indexed as

Machine LearningMycobacterium tuberculosisAnti-Bacterial AgentsDrug Resistance, BacterialGenome, BacterialHumansMicrobial Sensitivity TestsWhole Genome SequencingAnti-Bacterial Agents

Identifiers

PMID38940175
PMCPMC11211809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.